Published in J Biomater Appl on April 24, 2012
Liver regeneration. J Cell Physiol (2007) 6.69
Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng (2007) 1.68
Silsesquioxane nanocomposites as tissue implants. Plast Reconstr Surg (2007) 1.56
Hepatic tissue engineering. Transpl Immunol (2004) 1.36
Advances in bioartificial liver devices. Hepatology (2001) 1.30
Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg (1998) 1.29
Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med (2007) 1.18
Prospects for extracorporeal liver support. Gut (2004) 1.11
Biodegradable sponges for hepatocyte transplantation. J Biomed Mater Res (1995) 1.05
Emerging indications for albumin dialysis. Am J Gastroenterol (2005) 1.03
Engineering liver therapies for the future. Tissue Eng (2002) 1.01
Injectable liver: a novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytes. Tissue Eng (2006) 1.00
Toward development of an implantable tissue engineered liver. Biomaterials (1996) 0.99
The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: an in vitro study. Biomaterials (2005) 0.96
Highly porous polymer matrices as a three-dimensional culture system for hepatocytes. Cell Transplant (1997) 0.95
The endothelialization of polyhedral oligomeric silsesquioxane nanocomposites: an in vitro study. Cell Biochem Biophys (2006) 0.93
Bioartificial liver systems: why, what, whither? Regen Med (2008) 0.90
Review article: non-biological liver support in liver failure. Aliment Pharmacol Ther (2006) 0.89
Influence of flow conditions and matrix coatings on growth and differentiation of three-dimensionally cultured rat hepatocytes. Tissue Eng (2004) 0.88
Albumin regeneration in liver support-comparison of different methods. Ther Apher Dial (2006) 0.88
Synthesis and characterization of an isocyanate functionalized polyhedral oligosilsesquioxane and the subsequent formation of an organic-inorganic hybrid polyurethane. J Am Chem Soc (2002) 0.87
Liver support technology--an update. Xenotransplantation (2006) 0.86
Hybrid braided 3-D scaffold for bioartificial liver assist devices. J Biomater Sci Polym Ed (2007) 0.85
Extracellular matrix-enriched polymeric scaffolds as a substrate for hepatocyte cultures: in vitro and in vivo studies. Biomaterials (2005) 0.85
Fabrication and characterization of porous poly(L-lactide) scaffolds using solid-liquid phase separation. J Mater Sci Mater Med (2008) 0.85
Polyurethane foam/spheroid culture system using human hepatoblastoma cell line (Hep G2) as a possible new hybrid artificial liver. Cell Transplant (2001) 0.84
Acute liver failure: liver support therapies. Curr Opin Crit Care (2007) 0.84
Hepatocyte transplantation using biodegradable matrices in ascorbic acid-deficient rats: comparison with heterotopically transplanted liver grafts. Transplantation (2001) 0.83
Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: an in vitro evaluation. Eur J Vasc Endovasc Surg (2006) 0.83
Long-term hepatocyte transplantation using three-dimensional matrices. Transplant Proc (1999) 0.82
Hepatic tissue engineering on 3-dimensional biodegradable polymers within a pulsatile flow bioreactor. Dig Surg (2001) 0.82
Artificial liver support in the third millennium. Artif Cells Blood Substit Immobil Biotechnol (2003) 0.81
Hepatocytes maintain their function on basement membrane formed by epithelial cells. Biochem Biophys Res Commun (2007) 0.80
How can liver toxins be removed? Filtration and adsorption with the Prometheus system. Ther Apher Dial (2006) 0.80
Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study. World J Gastroenterol (2008) 0.80
The newly established human hepatocyte cell line: application for the bioartificial liver. J Hepatol (2005) 0.79
Hepatocyte dynamics in a three-dimensional rotating bioreactor. J Gastroenterol Hepatol (2007) 0.78
Hepatocyte hollow-fibre bioreactors: design, set-up, validation and applications. J Pharm Pharmacol (2003) 0.78
Bioreactor developments for tissue engineering applications by the example of the bioartificial liver. Adv Biochem Eng Biotechnol (2002) 0.77
Highly porous polymer matrices as a three-dimensional culture system for hepatocytes: initial results. Transplant Proc (1997) 0.77
Mars and Prometheus: our clinical experience in acute chronic liver failure. Transplant Proc (2008) 0.76
The promise of artificial liver replacement. Front Biosci (2008) 0.76
Concern Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet (2011) 5.79
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer. J Clin Oncol (2013) 2.90
Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases. Ann Surg Oncol (2009) 2.27
Liver ischemia/reperfusion injury: processes in inflammatory networks--a review. Liver Transpl (2010) 2.24
Nitric oxide is an essential mediator of the protective effects of remote ischaemic preconditioning in a mouse model of liver ischaemia/reperfusion injury. Clin Sci (Lond) (2011) 1.54
Efficacy of loco-regional ablation therapy of HCC in a population of liver transplanted patients. Dig Dis Sci (2007) 1.41
Role of stem cells in cancer therapy and cancer stem cells: a review. Cancer Cell Int (2007) 1.34
A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials (2012) 1.21
Laparoscopic versus open pancreas resection for pancreatic neuroendocrine tumours: a systematic review and meta-analysis. HPB (Oxford) (2013) 1.19
Biology of insulin-like growth factor binding protein-4 and its role in cancer (review). Int J Oncol (2006) 1.16
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl (2008) 1.14
Apoptosis and colorectal cancer: implications for therapy. Trends Mol Med (2009) 1.09
Use of multivariate analysis to suggest a new molecular classification of colorectal cancer. J Pathol (2013) 1.09
Cure of Acanthamoeba cerebral abscess in a liver transplant patient. Liver Transpl (2008) 1.08
Cryopreservation of encapsulated liver spheroids for a bioartificial liver: reducing latent cryoinjury using an ice nucleating agent. Tissue Eng Part C Methods (2011) 1.06
Role of endothelial nitric oxide synthase in remote ischemic preconditioning of the mouse liver. Liver Transpl (2011) 0.99
Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop. Basic Res Cardiol (2014) 0.98
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C. Hepatology (2014) 0.98
Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system. Biores Open Access (2013) 0.97
Effect of remote ischemic preconditioning on hepatic microcirculation and function in a rat model of hepatic ischemia reperfusion injury. HPB (Oxford) (2009) 0.97
Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine. Nanomedicine (Lond) (2011) 0.96
Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization. J Immunol (2007) 0.93
Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion. HPB (Oxford) (2010) 0.93
The nitric oxide pathway--evidence and mechanisms for protection against liver ischaemia reperfusion injury. Liver Int (2012) 0.93
A prospective study of isolated human hepatocyte function following liver resection for colorectal liver metastases: the effects of prior exposure to chemotherapy. J Hepatol (2006) 0.92
GMP cryopreservation of large volumes of cells for regenerative medicine: active control of the freezing process. Tissue Eng Part C Methods (2014) 0.89
Late hepatic artery thrombosis after orthotopic liver transplantation. Liver Transpl (2003) 0.88
Glycine maintains mitochondrial activity and bile composition following warm liver ischemia-reperfusion injury. J Gastroenterol Hepatol (2011) 0.88
Modulation of microcirculatory changes in the late phase of hepatic ischaemia-reperfusion injury by remote ischaemic preconditioning. HPB (Oxford) (2011) 0.88
Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment. Int J Oncol (2011) 0.87
Pretreatment with insulin-like growth factor I protects skeletal muscle cells against oxidative damage via PI3K/Akt and ERK1/2 MAPK pathways. Lab Invest (2010) 0.87
The effect of intraportal prostaglandin E1 on adhesion molecule expression, inflammatory modulator function, and histology in canine hepatic ischemia/reperfusion injury. J Surg Res (2006) 0.86
A mammographic image analysis method to detect and measure changes in breast density. Eur J Radiol (2004) 0.86
Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitus. Arterioscler Thromb Vasc Biol (2011) 0.86
Storage temperatures for cold-chain delivery in cell therapy: a study of alginate-encapsulated liver cell spheroids stored at -80°c or -170°c for up to 1 year. Tissue Eng Part C Methods (2012) 0.86
Does doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer? World J Surg Oncol (2009) 0.85
Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes. Biotechnol Appl Biochem (2004) 0.85
Techniques of flushing and reperfusion for liver transplantation. Cochrane Database Syst Rev (2012) 0.84
N-Acetylcysteine ameliorates the late phase of liver ischaemia/reperfusion injury in the rabbit with hepatic steatosis. Clin Sci (Lond) (2005) 0.84
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes. Gut (2013) 0.82
Duct-to-duct biliary reconstruction in orthotopic liver transplantation for primary sclerosing cholangitis: a viable and safe alternative. Transpl Int (2011) 0.81
A registration framework for the comparison of mammogram sequences. IEEE Trans Med Imaging (2005) 0.81
Critical parameter of burst pressure measurement in development of bypass grafts is highly dependent on methodology used. J Vasc Surg (2006) 0.81
Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles. Biol Trace Elem Res (2010) 0.81
The hepatic soluble guanylyl cyclase-cyclic guanosine monophosphate pathway mediates the protection of remote ischemic preconditioning on the microcirculation in liver ischemia-reperfusion injury. Transplantation (2012) 0.81
Evaluation of intraocular and orbital pressure in the management of orbital hemorrhage: an experimental model. Arch Ophthalmol (2008) 0.81
Candidate T cell epitopes of the human La/SSB autoantigen. Arthritis Rheum (2002) 0.80
Pharmacological interventions versus no pharmacological intervention for ischaemia reperfusion injury in liver resection surgery performed under vascular control. Cochrane Database Syst Rev (2009) 0.78
Anticoagulation after liver transplantation: a retrospective audit and case-control study. Blood Coagul Fibrinolysis (2009) 0.78
In vivo factors influencing tumour M2-pyruvate kinase level in human pancreatic cancer cell lines. Tumour Biol (2010) 0.78
Remote ischemic preconditioning by hindlimb occlusion prevents liver ischemic/reperfusion injury. Ann Surg (2011) 0.78
Applications and limitations of blood eosinophilia for the diagnosis of acute cellular rejection in liver transplantation. Am J Transplant (2003) 0.78
Aortic function is compromised in a rat model of polycystic ovary syndrome. Hum Reprod (2005) 0.78
Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular control. Cochrane Database Syst Rev (2009) 0.78
A meta-analysis of the impact of the two-layer method of preservation on human pancreatic islet transplantation. Cell Transplant (2008) 0.77
Hepato-biliary clinical trials and their inclusion in the Cochrane Hepato-Biliary Group register and reviews. J Gastroenterol Hepatol (2011) 0.77
Attenuation of warm ischemia-reperfusion injury in the liver by bucillamine through decreased neutrophil activation and Bax/Bcl-2 modulation. J Gastroenterol Hepatol (2010) 0.77
Intracellular oxygenation and cytochrome oxidase C activity in ischemic preconditioning of steatotic rabbit liver. Am J Surg (2010) 0.77
Limited penetration of perfluorocarbon in porcine pancreas preserved by two-layer method with (19)fluorine magnetic resonance spectroscopy and headspace gas chromatography. Cell Transplant (2010) 0.76
IGF-I activates caspases 3/7, 8 and 9 but does not induce cell death in colorectal cancer cells. BMC Cancer (2009) 0.76
Portal vein embolization prior to extensive resection for colorectal liver metastases. Ann Surg Oncol (2009) 0.76
Bucillamine improves hepatic microcirculation and reduces hepatocellular injury after liver warm ischaemia-reperfusion injury. HPB (Oxford) (2009) 0.76
Cancer antibody enhanced real time imaging cell probes--a novel theranostic tool using polymer linked carbon nanotubes and quantum dots. Anticancer Agents Med Chem (2013) 0.75
Donor liver preservation and stimulation of adhesion molecules : cold preservation initiates the cascade. Cryo Letters (2003) 0.75
Altered sensitivity to nitric oxide donors, induced by intravascular infusion of quantum dots, in murine mesenteric arteries. Nanomedicine (2012) 0.75
Spyglass cholangioscopy in the evaluation of an intra-hepatic biliary lesion. Dig Endosc (2011) 0.75
Pro-inflammatory agents accumulate during donor liver cold preservation: a study on increased adhesion molecule expression and abrogation by curcumin in cultured endothelial cells. Cryobiology (2003) 0.75
A dip into history: science and publication in cryobiology 150 years ago. Cryo Letters (2003) 0.75
Cryobiology and UNESCO in the 21st century: questions on the global picture. Cryo Letters (2003) 0.75